- Home
- ACIU vs WRN Comparison
ACIU vs WRN Comparison
Compare ACIU & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- WRN
- Stock Information
- Founded
- ACIU 2003
- WRN 2006
- Country
- ACIU Switzerland
- WRN Canada
- Employees
- ACIU N/A
- WRN N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- WRN Metal Mining
- Sector
- ACIU Health Care
- WRN Basic Materials
- Exchange
- ACIU Nasdaq
- WRN Nasdaq
- Market Cap
- ACIU 173.7M
- WRN 226.0M
- IPO Year
- ACIU 2016
- WRN N/A
- Fundamental
- Price
- ACIU $1.68
- WRN $1.16
- Analyst Decision
- ACIU Strong Buy
- WRN Strong Buy
- Analyst Count
- ACIU 2
- WRN 1
- Target Price
- ACIU $10.00
- WRN $4.25
- AVG Volume (30 Days)
- ACIU 133.4K
- WRN 384.5K
- Earning Date
- ACIU 04-30-2025
- WRN 05-20-2025
- Dividend Yield
- ACIU N/A
- WRN N/A
- EPS Growth
- ACIU N/A
- WRN N/A
- EPS
- ACIU N/A
- WRN N/A
- Revenue
- ACIU $32,014,254.00
- WRN N/A
- Revenue This Year
- ACIU N/A
- WRN N/A
- Revenue Next Year
- ACIU $676.94
- WRN N/A
- P/E Ratio
- ACIU N/A
- WRN N/A
- Revenue Growth
- ACIU 91.20
- WRN N/A
- 52 Week Low
- ACIU $1.43
- WRN $0.90
- 52 Week High
- ACIU $4.98
- WRN $1.66
- Technical
- Relative Strength Index (RSI)
- ACIU 46.75
- WRN 53.85
- Support Level
- ACIU $1.55
- WRN $1.09
- Resistance Level
- ACIU $1.79
- WRN $1.20
- Average True Range (ATR)
- ACIU 0.10
- WRN 0.05
- MACD
- ACIU 0.03
- WRN 0.00
- Stochastic Oscillator
- ACIU 66.67
- WRN 65.46
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).